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INTRODUCTION
1INTRODUCTION
      With increasing life expectancy geriatric population (people aged
65 and above) contribute to significant percentage of the World
population.
         India  is  in  a  phase  of  demographic  transition.  As  per  the  2001
census, the population of the elderly in India was 49 million as
compared with 20 million in 1951. It has been projected that by the year
2050, the number of elderly people would rise to about 324 million.
Current life expectancy is 62.3years for males and 65.3years for
females.
      They also contribute to significant percentage of respiratory
diseases. Aging has been shown to be associated with gradual decline in
many aspects of pulmonary functions, waning of immunity and the
immunological mechanisms show a declining efficiency as the
antibodies form much less rapidly in old age than in younger adulthood.
     This study is to find the current spectrum of respiratory diseases
in geriatric population in a tertiary care centre.
AIM
2AIM
To study the current profile of Respiratory diseases in
Geriatric Population attending a tertiary care centre
REVIEW OF
LITERATURE
3REVIEW OF THE LITERATURE
The primary search engines used were, pubmed, google scholar,
hand searching of articles and standard textbook references.
COPD IN GERIATRIC PATIENTS
Some researches are of the view  that COPD may be a disease of
accelerated aging process. Lee et al in CurrOpinPulm Med. 2011
Mar;17(2):90-7(1), substantiates this. He says accelerated aging due to
exposure to cigarette smoke is hypothesized to induce rapid progression
of COPD. Recent studies have shown that COPD patients have
enhanced expression of senescence-associated proteins in the lung and
in the peripheral circulation compared to healthy controls. Murine
models of accelerated aging demonstrate spontaneous emphysematous
changes in the lungs, while lungs of COPD patients demonstrate
enhanced markers of senescence in fibroblasts and alveolar cells. More
recently, studies of telomeres, which shorten with cellular aging, have
shown that COPD patients may experience accelerated telomere attrition
compared with healthy controls. However, studies to date have been
relatively small and have produced heterogeneous results.  In chronic
respir dis 2011;8(2) :143-51,Jarad N(2) describes the out come of COPD
patients in geriatic patients.He says “ Features of importance to old age
4include increased prevalence of COPD in non-smokers and rise in the
rate of systemic co morbidities. In addition, acute exacerbations in older
patients have poorer outcome, manifesting by increase in the rate of
hospitalisation, greater length of stay, increase of the rate of re-
hospitalisation and in mortality rate. Impaired cognitive functions as
well as problems affecting hand joints make using inhaled medications
less reliable which leads to further deterioration of outcome of care.
Even for those who are competent in using inhalers, the evidence for
their efficacy in older patients is not certain”. So while treating geriatric
patients with COPD all these factors should be kept in mind. The role of
rehabilitation in Geriatric patients has also been extensively dealt with.
“Comprehensive peri operative rehabilitation appears to be effective in
high-risk patients with severe COPD who need surgery for abdominal
cancer” Disabil Rehabil. 2012;34(2):174-7(3).
COMMUNITY ACQUIRED PNEUMONIA  IN THE ELDERLY
It is of common knowledge that age plays a very important part in
the outcome of patients with CAP.But it is not the age alone which plays
a part but the associated co morbid conditions, associated with
aging,which also plays a role in the outcome.Sliql et al, CurrOpin Infect
Dis. 2011 Apr;24(2):142-7(7), opines that ,“ Poorer outcomes in the
elderly with CAP have been related to severity of disease, co morbid
5disease burden, functional status, and frailty, but not to age alone”. CAP
presents differently in the adult and the elderly. One cannot expect the
same typical symptoms in the elderly. Akhee S et al, South Med J. 1997
Mar; 90 (3):296-8(8), has compared mortality with the absence of fever
and leucocytosis. Elderly patients with community-acquired pneumonia
may not have a systemic inflammatory response characterized by fever
and leukocytosis. They compared lack of fever and leukocytosis with
mortality in elderly patients with community-acquired pneumonia.
Patients with fever and leukocytosis were compared with those without
fever and leukocytosis. Comparison of the two groups by unpaired, two-
tailed t test showed that lack of fever and leukocytosis correlated with
mortality. Hospitalized elderly patients who have community-acquired
pneumonia without fever and leukocytosis are seven times more likely
to die than those who have these symptoms. Finally he concludes by
saying that the addition of immune modulators like Granulocyte colony
stimulating factors should be considered in this group of patients.
Investigators have also paid attention to the causative organisms,
clinical characteristics, and outcomes. Fernández-Sabé N et al in
Medicine (Baltimore). 2003 May; 82(3):159-69(9)he has documented
his  results  like  this,  “We  performed  an  observational  analysis  of
prospectively collected data on 1,474 adult patients who were
6hospitalized for community-acquired pneumonia; 1,169 patients were
under 80 years of age and 305 (21%) patients were over 80 years ("very
elderly"). Mean patient ages were 60 years in the former group and 85
years in the latter group. Severely immune suppressed patients and
nursing-home residents were not included. Co morbidities significantly
associated with older age were chronic obstructive pulmonary disease,
chronic heart disease, and dementia. The most common causative
organism was Streptococcus pneumoniae (23% in both groups).
Aspiration pneumonia was more frequent in the very elderly (5% in
younger patients versus 10% in the very elderly); Legionella
pneumophila (8% in younger patients versus 1% in the very elderly) and
atypical agents (7% in younger patients versus 1% in the very elderly)
were rarely recorded in the very elderly. While very elderly patients
complained less frequently of pleuritic chest pain, headache, and
myalgia, they were more likely to have absence of fever and altered
mental status on admission. No significant differences were observed
between groups as regards incidence of classic bacterial pneumonia
syndrome (60% versus 59%) in 343 patients with pneumococcal
pneumonia. The development of complications (26% in younger versus
32% in very elderly patients) as well as early mortality (2% in younger
versus 7% in very elderly patients) and overall mortality (6% in younger
versus 15% very elderly patients) were significantly higher in very
7elderly patients. Acute respiratory failure and shock/multi organ failure
were the most frequent causes of death, especially of early mortality.
Factors independently associated with 30-day mortality in the very
elderly were altered mental status on admission (odds ratio, 3.69), shock
(odds ratio, 10.69), respiratory failure (odds ratio, 3.50), renal
insufficiency (odds ratio, 5.83), and Gram-negative pneumonia (odds
ratio, 20.27).”One important concern about this study is patients in the
very elderly age group and nursing home residents have not been
included. This problem has in part been solved by Australian researchers
Chong et al where they have compared nursing home acquired and
community acquired pneumonia in the elderly age group.Although there
were no significant differences in CRP, WBC, and body temperature at
admission and duration of hospitalization, the degree of independency
of the nursing home group was significantly lower than the community
group. As the degree of independency became worse, the length of
hospitalization extended and mortality increased. Bacteriological
findings of sputum culture showed that methicillin-resistant
Staphylococcus aureus (MRSA) was cultured in 20 cases (19%) of the
nursing home group and 18 cases (13%) of the community group. In
isolated analysis of total care cases, MRSA positive rates were similar in
the nursing home group (17/58; 29%) and the community group (8/30;
27%). Only 1 case with penicillin-susceptible Streptococcus
8pneumoniae (PSSP) was found in the nursing home group, however 7
species of PSSP were cultured in the community group, including 5 self-
help cases. Pseudomonas aeruginosa was cultured in 8 patients of each
group, and most of them were total care cases. We concluded that the
difference in frequency and species of bacteria depended on the
condition  of  patients,  rather  than  the  environment,  and  differences  in
conditions might lead to differences in clinical features.
SLEEP APNOEA
The prevalence of sleep apnoea among the elderly group is
increasing. The adverse outcome associated with sleep apnoea is also
increasing. This has been dealt by Iyer SR in J Assoc Physicians
India.,2010 Jul; 58: 442-6(10). Stroke is a serious health problem and is
chiefly a disorder of the elderly population. Several modifiable and non-
modifiable risk factors have been studied. The association of sleep
disorders and stroke is exciting. Obstructive sleep apnoea (OSA) which
is now considered a systemic disease significantly increases the risk of
stroke and death from any cause and the increase is independent of other
risk factors including hypertension. There is high prevalence of OSA in
the elderly. OSA affects the cerebral hemodynamics adversely. There
appears to be a bi-directional relation between sleep disordered
breathing (SDB) and cerebrovascular accidents. Strokes can themselves
9generate SDB. The presence of OSA in stroke patients is associated with
poor outcome. Cyclical hypoxia and sympathetic stimulation has
deleterious effects on cardiovascular, cerebro vascular and metabolic
functions. The effects are particularly important in existing ischemic
brain injury. Use of continuous positive airway pressure in OSA patients
is rewarding. One important conclusion has been made at the end of the
study. The use of naso gastric tube in the management of these patients
results in the narrowing if the pharynx which already has been
compromised in sleep apnoea patients.
DIFFUSE PARENCHYMAL LUNG DISEASE
       Aging is associated with increased susceptibility to a variety of
chronic diseases, including type 2 diabetes mellitus, cancer, and
neurological diseases. Lung pathologies are not the exception, and the
prevalence of several interstitial lung diseases (ILDs), primarily
idiopathic pulmonary fibrosis, has been found to increase considerably
with age. Immunosenescence, oxidative stress, abnormal shortening of
telomeres, apoptosis, and epigenetic changes affecting gene expression
have been proposed to contribute to the aging process, and aging-
associated diseases. SeminRespirCrit Care Med 2010; 31(5): 607-
617.Moise Sain et al(11).
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RESPIRATORY TRACT INFECTIONS IN GERIATRIC
POPULATION
Infections, particularly respiratory tract infections, are common in
elderly individuals, resulting in decreased daily activity, prolonged
recovery times, increased health care service use, and more frequent
complications, including death.
UPPER RESPIRATORY TRACT INFECTION
      The International Classification of health problems in primary
health care defines “upper respiratory tract infections” as acute
inflammation of nasal or pharyngeal mucosa in the absence of other
specifically defined respiratory infection. It consist of nasopharyngitis
(common cold),sinusitis, pharyngitis, otitis media, laryngitis and acute
bronchitis.
ACUTE BRONCHITIS
Diagnostic Criteria
Atleast 2 of the following signs and symptoms had to be present
to meet the criteria of acute bronchitis: increased frequency and severity
of cough, new or increased sputum production, burning substernal chest
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discomfort with coughing or deep inspiration, and fever (temperature
?38?C). Radiologic evidence of pneumonia excluded this diagnosis(4).
PNEUMONIA
Pneumonia is defined as inflammation and consolidation of lung
tissue due to an infectious agent and characterised by radiographic
infiltrate. Pneumonia can be classified as follows:
• Community acquired pneumonia
• Nosocomial pneumonia
o Hospital acquired pneumonia
o Health care associated pneumonia
o Ventilator associated pneumonia
COMMUNITY ACQUIRED PNEUMONIA
In older patients apart from organisms encountered in younger
people such as H.influenza, Moraxella catarrhalis, aerobic gram
negative bacillus, Enterobacter, E.coli, Serratia marcescens, Klebsiella ,
Proteus, Pseudomonas and Acinetobacter.  They are usually associated
with pre-existing respiratory illness such as COPD.
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HOSPITAL ACQUIRED PNEUMONIA(HAP)
      Pneumonia that is neither present nor incubating at the time of
admission and occurring after 48 hours of admission.
VENTILATOR ASSOCIATED PNEUMONIA
• Complicates Intubation Process
• Early onset - occurring in 48-72hrs
• Late onset- occurring after 72hrs
HEALTH CARE ASSSOCIATED PNEUMONIA
• Patients with pneumonia developing in 2 to 90 days of
hospitalization
• Resident of nursing home
• Recent exposure to hemodialysis, I.V antibiotics chemotherapy,
wound care
• May be residing in a community but infected with organism
similar to HAP.
PULMONARY TUBERCULOSIS IN GERIATRIC POPULATION
Pulmonary tuberculosis is a chronic infectious disease of the lung
caused by Mycobacterium tuberculosis.
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     In old people tuberculosis can be either due to exogenous
reinfection or endogenous reactivation. In this age group there is an
increased risk of tuberculosis infection due to natural aging process of
the immune system. Several factors apart from aging contribute to
decline in immunity. These are underweight, malnutrition, cancer,
diabetes mellitus, gastrointestinal surgery, immunosuppressive treatment
like corticosteroids, smoking and HIV.
CLINICAL FEATURES
     Elderly subjects with TB may present with systemic
manifestations of TB and a paucity of respiratory symptoms is observed
in the elderly(12,13).As compared to young adults clinical presentation
of TB in elderly may be atypical with more of constitutional symptoms
(12,13 ).
DIAGNOSIS
Microscopy of a sputum smear prepared by Ziel Neelson method
detecting the acid fast bacilli. Chest radiograph  or CT chest showing
features suggestive of active tuberculosis.
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PULMONARY TUBERCULOSIS SEQUELAE
Sequela of  tuberculosis  (TB sequela)  is  defined as the state with
various secondary complications after healing of TB, such as chronic
respiratory failure (CRF), corpulmonale or chronic pulmonary
inflammation. Pathophysiology of TB sequelae is consisted of disturbed
pulmonary function, chronic respiratory failure, sleep disorder and
pulmonary hypertension. In addition, secondary pulmonary infection
with mycosis or nontuberculous mycobacteriosis (NTM) is difficult to
be controlled(14,15 ).
 In  a narrow sense, the sequelae is a pathological status that is
caused by many patho-anatomical changes in the healing process of
pulmonary tuberculosis and need clinical treatment for many symptoms.
The pulmonary tuberculosis sequelae include secondary infection such
as aspergillosis, atypical mycobacteriosis and bacterial airway infection.
In a broad sense, the sequelae also represent a pathological status with
many symptoms after treatment that is caused by injuries in various
organs with tuberculosis(14,15 ).
        PT sequelae consist of repeated bacterial infection of lower
respiratory tract, pulmonary aspergilloma, atypical mycobacteriosis and
chronic respiratory failure.
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COPD IN GERIATRIC POPULATION
DEFINITION
Chronic Obstructive Pulmonary Disease (COPD) is a preventable
and treatable disease with some significant extrapulmonary effects that
may contribute to the severity in individual patients. Its pulmonary
component is characterized by airflow limitation that is not fully
reversible. The airflow limitation is usually progressive and associated
with an abnormal inflammatory response of the lung to noxious particles
or gases.
     The chronic airflow limitation characteristic of COPD is caused
by  a  mixture  of   small  airway  disease  (obstructive  bronchiolitis)  and
parenchymal destruction (emphysema), the relative contributions of
which vary from person to person.
CLINICAL FEATURES
           Characterized by chronic cough , sputum production and
breathlessness.
DIAGNOSTIC CRITERIA
Post bronchodilator FEV1 /FVC<0.70 or FVC less than 0.8.
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AECOPD DEFINITION
An exacerbation of COPD is defined as an event in the natural
course of the disease characterised by a change in the patients base line
dyspnoea , cough and / or sputum that is beyond normal day to day
variation, is acute in onset, and may warrant a change in regular
medication in patient with under lying COPD.
BRONCHIAL ASTHMA IN ELDERLY
DEFINITION
Bronchial asthma is defined as a chronic inflammatory disorder of
the airways in which many cells  and cellular  elements play a role .The
chronic inflammation is associated with airway hyper responsiveness
that leads to recurrent episodes of wheezing, breathlessness, chest
tightness, and coughing particularly at night or in the early morning.
These episodes are usually associated with widespread, but variable,
airflow obstruction within the lung that is often reversible either
spontaneously or with treatment.
CLINICAL DIAGNOSIS
      Clinical diagnosis of asthma is often prompted by symptoms such
as episodic breathlessness, wheezing, cough, and chest tightness.
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Episodic symptoms after an incidental allergen exposure, seasonal
variability of symptoms and a positive family history of asthma and
atopic disease are also helpful diagnostic guides.
CRITERIA FOR DIAGNOSIS
? Clinical features suggestive of bronchial asthma.
? SPIROMETRY-A diagnosis of asthma was made  according to
the  ATS  criteria  depending  on  the  degree  of  reversibility  of
FEV1 which is generally accepted as ? 12% and ? 200 ml
from the pre bronchodilator value.
ACUTE EXACERBATION
Transient worsening of asthma may occur as a result of exposure
to risk factors for asthma symptoms, or triggers, such as exercise, air
pollutants, and even certain weather conditions(e.g., thunderstorms).
More prolonged worsening is usually due to viral infections of the upper
respiratory tract( particularly rhinovirus and respiratory syncytial virus)
or allergen exposure which increases inflammation in the lower airways
(acute or chronic inflammation) that may persist for several days or
weeks.
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BRONCHIECTASIS
DEFINITION
    Bronchiectasis is a morphologic term used to describe the
abnormal irreversibly dilated and often thick walled bronchi.
Bronchiectasis represents the end stage of  a variety of pathological
processes that cause destruction of the bronchial wall and its
surrounding supporting tissues. The clinical manifestations include
chronic cough and copious mucopurulent expectoration, often lasting
months to years. Bronchiectasis shares many features with chronic
bronchitis , including inflamed and easily collapsible airways, airflow
obstruction on spirometry , and frequent exacerbations.
CLINICAL FEATURES
 The classical clinical manifestations of bronchiectasis are daily
cough and mucopurulent sputum production. Cough is invariably
present and is often the only symptom for years. Purulent , tenacious
sputum production often intermittent , frequently worse in the morning
is present in most patients. Dry bronchiectasis is occasionally seen.
Hemoptysis may be seen in 40 to 70% of the patients and may vary
from blood streaks to large clots. Increasing cough, dyspnea , volume of
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sputum production, fever, hemoptysis, and chest pain are hallmarks of
exacerbations.
     Chest auscultations reveal findings of early and mid-inspiratory
crackles as well as diffuse rhonchi and prolonged expiration. Bronchial
breath sounds may be heard in severe cases or in patient with
complicating pneumonia. In severe advanced cases, there may be
evidence of respiratory insufficiency and corpulmonale.
CLASSIFICATION USING RADIOLOGY
Bronchiectasis may be classified by pathological features , and
radiographic appearance as follows.
• Cylindrical bronchiectasis
• Varicose bronchiectasis
• Saccular (cystic bronchiectasis)
Diagnostic criteria
 HRCT is the imaging modality of choice to establish the presence
of bronchiectasis and to determine its precise extent. The characteristic
findings are.
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• An internal bronchial diameter greater than that of the adjacent
pulmonary artery.
• Lack  of  bronchial  tapering,  defined  as  a  bronchus  that  has  the
same diameter as its parent branch for a distance of more than
2cm.
• Visualization of bronchi within 1cm of the costal pleura.
• Visualization of bronchi abutting the mediastinal pleura
• Bronchial wall thickening.
LUNG CANCER IN GERIATRIC POPULATION
Lung cancer is the phenotypic consequence of an accumulation of
genetic changes in airway epithelial cells that result in unrestrained
cellular proliferation. They are basically classified as Non-small cell
carcinoma and Small cell carcinoma.
WHO Classification  of Malignant epithelial Non-small cell Lung
Tumors
• Squamous cell carcinoma
• Adenocarcinoma
• Adenosquamous carcinoma
• Large cell carcinoma
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• Sarcomatoid  carcinoma
• Carcinoid tumour
• Salivary gland tumors
ADENOCARCINOMA
       Adenocarcinoma of the lung is a form of non-small cell lung
cancer. Eighty percent of lung cancers are non-small cell cancers, and of
these, about 50% are adenocarcinomas. Adenocarcinoma of the lung
begins in the outer parts of the lung, and it can be present for a long time
before it is diagnosed. It is the type of lung cancer most commonly seen
in women and is often seen in non-smokers. The most common type of
lung cancer in lifelong non-smokers is the adenocarcinoma. This cancer
usually is seen peripherally in the lungs, as opposed to small cell lung
cancer and squamous cell lung cancer, which both tend to be more
centrally located. The adenocarcinoma has an increased incidence in
smokers, but is also the most common type of lung cancer seen in non-
smokers.
       Adenocarcinoma of the lung tends to stain mucin positive as it is
derived from the mucus producing glands of the lungs. Similar to other
adenocarcinoma, if the tumor is well differentiated (low grading) it will
resemble the normal glandular structure. Poorly differentiated
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adenocarcinoma will not resemble the normal glands (high grade) and
will be detected by seeing that they stain positive for mucin(which the
glands produce).
SQUAMOUS CELL CARCINOMA
          Squamous cell lung cancer is a form of Non-small cell lung
cancer. Squamous cell lung cancers usually begin in the bronchial tubes
(large airways) in the central part of the lungs.
         Squamous cell carcinoma cells are large, flattened and stratified
with a high cytoplasm to nucleus ratio. Key diagnostic features include
the presence of intracytoplasmic keratin which may be linked to the
presence of intercellular bridges and squamous pearl formation. Most
squamous cell carcinomas arise centrally within the main, lobar,
segmental or sub segmental bronchi but some occur more peripherally.
The tumour mass generally extends into the lumen of the airway with
invasion into the underlying wall.
SMALL CELL LUNG CARCINOMA
           Small cell lung cancer (SCLC) is a tumour of extremes.
Untreated, it is one of the most highly virulent malignancies known,
with a life expectancy best measured in days to weeks. On the other
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hand, it displays exquisite chemo sensitivity, resulting in partial or
complete responses in vast majority of cases. Unfortunately, although
many patients can be rendered free of clinical evidence of disease, most
quickly relapse and die from this malignancy.
          Like all other lung cancers, SCLC is linked to a variety of
environmental risk factors. By far the strongest association is with the
use of tobacco: Up to 98% of SCLC patients have a history of smoking.
Occupational risks for SCLC include exposure to bischloromethyl
ethers, nickel, vinyl chloride, asbestos, cadmium, and radon daughters
(in uranium miners). Other types of radiation exposure also appear to be
significant risk factors, with an increased incidence of SCLC in atomic
bomb survivors and patients.
DIFFUSE PULMONARY LUNG DISEASE IN GERIATRIC
POPULATION
Advancing age is associated with increased risk for some forms of
interstitial lung disease (ILD), and this risk is especially reflected by the
considerably increased incidence of idiopathic pulmonary fibrosis (IPF)
in  the  elderly.  Although  the  causes  of  this  increased  risk  are  not  well-
defined, both ageing and IPF have been associated with shortening of
telomeres due to telomerase deficiency. Thoracic imaging with high-
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resolution computed tomographic (HRCT) scanning plays a key role in
the diagnosis of ILD in the elderly, and a characteristic appearance of
the lung parenchymal changes on HRCT may provide a confident
diagnosis and obviate the need for invasive testing such as surgical lung
biopsy. An effective treatment for IPF remains elusive, but many
patients will benefit from supportive care and treatment of various co-
morbid conditions that are often found in patients with IPF(29).
PNEUMOCONIOSIS IN GERIATRIC POPULATION
DEFINITION
The accumulation of dust in the lungs and tissue reactions to its
presence. Commonest pneumoconiosis includes
• Silicosis
• Coal worker pneumoconiosis
• Asbestosis
• Beryliosis
SILICOSIS
Silicosis is fibrotic disease of the lungs caused by the inhalation,
retention, and pulmonary reaction to crystalline silica. There are three
forms of silicosis.
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• Acute silicosis
• Accelerated silicosis
• Chronic silicosis
CHRONIC SILICOSIS
      Chronic silicosis occurs after a latency of 15years. Radiological
features includes multiple nodules that are bilateral, located in upper
lung zones, and associated with basilar emphysema.  Hilar or
mediastinal lymph nodes may show egg shell calcification.
PROGRESSIVE MASSIVE FIBROSIS
      Progressive massive fibrosis(PMF), also called complicated
silicosis and conglomerate silicosis, is defined as nodules> 1cm in
diameter.   CT  is  confirmatory  demonstrating  a  peripheral  zone  of
paracicatricial emphysema, rounded or ovoid mases of  PMF. The outer
margin of PMF often parallels the contour of  chest wall. Large lesions
often show irregular low attenuation regions indicative of avascular
necrosis, and cavitation may occur.
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PLEURAL DISEASES IN ELDERLY
Pleural diseases in geriatric population consist of pleural effusion,
primary and secondary malignancy, pneumothorax.  Pleural effusion
can be classified as exudative and transudative. Exudative Pleural
efffusion in the elderly includes infections, primary and secondary
malignancy and chylothorax.
TUBERCULOUS PLEURAL EFFUSION
           When a tuberculous pleural effusion occurs in the absence of
radiologically apparent TB, it may be the sequel to a primary infection 6
to 12 weeks previously or it may represent reactivation TB (32).
In industrialized countries, more pleural effusions may be due to
reactivation than are due to post primary infection (32). However, in a
recent study from San Francisco, pleural TB cases were approximately
two times more likely to be clustered than were pulmonary TB and three
times more likely to be clustered than non respiratory TB cases(32).
The tuberculous pleural effusion is thought to result from rupture
of a sub pleural caseous focus in the lung into pleural space (33).
Supporting evidence comes from the operative findings of Stead et al
(34), who reported that they could demonstrate a caseous tuberculous
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focus in the lung contiguous with the diseased pleura in 12 to 15 patients
with  tuberculous  pleuritis.  The  remaining  three  patients  in  this  series
were found to have parenchymal TB, although these patients did not
have caseous foci adjacent  to the pleura.
          It appears that delayed hypersensitivity plays a large role in the
pathogenesis of tuberculous pleural effusion. The hypersensitivity
reaction is initiated when tuberculous protein gains access to the pleural
space.
        It is probable that delayed hypersensitivity also plays a large role
in the development of tuberculous pleural effusions in humans. The
mycobacterial cultures of the pleural fluid from most patients with
tuberculous pleural effusions are negative (35,36).
        Although delayed hypersensitivity to tuberculous protein is
probably responsible for most clinical manifestations of tuberculous
pleuritis, many patients when first evaluated have a negative PPD skin
test. The explanation for this paradox may be a combination of two
factors. First, in some (37), but not in all (38) patients with tuberculous
pleuritis, a circulating mononuclear adherent cell suppresses the
specifically sensitized circulating T lymphocytes in the peripheral blood.
Second, there may be a sequestration of PPD-reactive T lymphocytes in
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the pleural space involving both Leu-2(suppressor/cytotoxic) and Leu-
3(helper) positive T cells (38).
MALIGNANT PLEURAL EFFUSION
         Carcinomas of the lung and breast and lymphomas account for
approximately 75% of malignant pleural effusions. Lung cancer is the
leading cause of malignant pleural effusion (40). When patients with
lung cancer are first evaluated, approximately 15% have a pleural
effusion (41).
MATERIALS AND
METHODS
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MATERIALS AND METHODS
STUDY DESIGN
       This is Prospective (Observational) study designed to find the
current profile of respiratory diseases in Geriatric population.
 STUDY CENTER:
? Institute of Thoracic Medicine, Chetpet.
? Department of Thoracic Medicine, Government Rajiv Gandhi
General Hospital, Madras Medical College, Chennai-3.
STUDY DURATION
        February 2011 to October 2011
INCLUSION CRITERIA
Consenting patients with age 65 years or more with Respiratory
Symptoms.
EXCLUSION CRITERIA
? Patients with age less than 65.
? Patients not giving consent.
30
STUDY PROCEDURE
Geriatric patients, those consenting, with respiratory complaints
attending Institute of Thoracic Medicine, chetpet and Department of
Thoracic Medicine, Rajiv Gandhi Government General Hospital,
Chennai,  were taken up for study.
           In this study 1234 patients were studied in which males were 773
and females were 461.  394 patient required inpatient care. 890 patients
belong to the age group 65-74years and 344 in 75+years age group.
            Routine investigations such as chest skiagram, sputum NT C/S,
sputum gram stain, sputum AFB and spirometry were done.
      Those patient requiring inpatient care were admitted in the
Thoracic Medicine ward, Rajiv Gandhi Government General Hospital.
Apart from above mentioned investigation they were subjected to
further investigation, as per need, such a Renal function test, Liver
function test, blood culture, ECG, ECHO, CT CHEST, Bronchoscopy,
thoracocentesis, pleural biopsy and CT guided biopsy.
RESULTS
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RESULTS
           In this study 1234 patients were studied in which males were 773
and females were 461.  394 patient required inpatient care. 890 patients
belong to the age group 65-74years and 344 in 75+years age group.
Respiratory morbidity profile of these patients are as follows.
32
DEMOGRAPHY
AGE AND SEX DISTRIBUTION
65-74yrs 75+yrs
MALE 555 218
FEMALE 335 126
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RESPIRATORY DIAGNOSIS
DIAGNOSIS TOTAL
PERCENTAGE
(N=1234)
UPPER RESPIRATORY TRACT
INFECTION 351 28.44
ACUTE BRONCHITIS 108 8.75
CHRONIC OBSTRUCTIVE
PULMONARY DISEASE 298 24.14
BRONCHIAL ASTHMA 117 9.48
PULMONARY TUBERCULOSIS 106 8.58
PIULMONARY TUBECULOSIS
SEQUALAE 128 10.37
CARCINOMA LUNG 96 7.78
PNEUMONIA 60 4.86
BRONCHIECTASIS 40 3.24
DIFFUSE PARENCHYMAL LUNG
DISEASE 17
1.37
PNEUMOCONIOSIS 1 0.08
PLEURAL DISEASES 30 2.43
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RESPIRATORY DIAGNOSIS
SEX DISTRIBUTION
DIAGNOSIS
MALE
(N = 773)
%
FEMALE
(N=461)
%
UPPER RESPIRATORY TRACT
INFECTION 30.66 24.73
ACUTE BRONCHITIS 9.18 8.02
COPD 26.2 20.6
BRONCHIAL ASTHMA 6.8 13.9
PULMONARY TUBERCULOSIS 7.6 10.2
PULMONARY TUBERCULOSIS
SEQUALAE 9.6 11.7
LUNG CANCER 8.79 6.03
PNEUMONIA 4.1 6.07
BRONCHIECTASIS 2.2 4.99
DIFFUSE PARENCHYMAL  LUNG
DISEASE 1.8 0.65
PNEUMOCONIOSIS 0.12 0
PLEURAL DISEASES 2.32 2.6
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RESPIRATORY DIAGNOSIS
AGE DISTRIBUTION
DIAGNOSIS
65-74 yrs
(N=890)
%
75+ yrs
(N=344)
%
UPPER RESPIRATORY TRACT
INFECTION 29.32 26.32
ACUTE BRONCHITIS 8.98 8.13
COPD 23.3 26.16
BRONCHIAL ASTHMA 11.68 3.77
PULMONARY TUBERCULOSIS 7.52 11.33
PULMONARY TUBERCULOSIS
SEQUALAE 9.1 13.66
CA LUNG 6.29 11.62
PNEUMONIA 3.48 8.43
BRONCHIECTASIS 3.93 1.45
DIFFUSE PARENCHYMAL LUNG
DISEASE 1.79 0.58
PNEUMOCONIOSIS 0.11 0
PLEURAL DISEASES 2.47 2.32
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INPATIENT DIAGNOSIS
DIAGNOSIS TOTAL
PERCENT
AGE
(N=424)
ACUTE EXACERBATION  OF COPD 114 26.88
ASTHMA EXACERBATION 24 5.66
PULMONARY TUBERCULOSIS 36 8.49
PULMONARY TUBERCULOSIS
SEQUELAE
39 9.19
LUNG CANCER 96 22.64
PNEUMONIA 55 12.97
BRONCHIECTASIS 12 2.83
DIFFUSE PARENCHYMAL LUNG
DISEASE
17 4.00
PNEUMOCONIOSIS 1 0.24
PLEURAL DISEASES 30 7.07
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INPATIENT DIAGNOSIS
SEX DISTRIBUTION
DIAGNOSIS
MALE
(N=259)
%
FEMALE
(N=165)
%
ACUTE EXACERBATION OF
COPD
27.80 25.45
ASTHMA EXACERBATION 3.08 9.70
PULMONARY TUBERCULOSIS 7.72 9.70
PULMONARY TUBERCULOSIS
SEQUELAE
8.1 10.90
LUNG CANCER 26.25 16.97
PNEUMONIA 11.58 15.15
BRONCHIECTASIS 2.70 3.03
DIFFUSE PARENCHYMAL LUNG
DISEASE
5.40 1.81
PNEUMOCONIOSIS 0.39 0
PLEURAL DISEASES 6.95 7.27
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UPPER RESPIRATORY TRACT INFECTION
AGE AND SEX DISTRIBUTION
65-74yrs 75+yrs
MALE 176 61
FEMALE 85 29
39
ACUTE BRONCHITIS
65-74yrs 75+yrs
MALE 52 19
FEMALE 28 9
40
PNEUMONIA
MALE FEMALE
COMMUNITY ACQUIRED PNEUMONIA 32 28
HOSPITAL ACQUIRED PNEUMONIA 0 0
VENTILATOR ASSOCIATED PNEUMONIA 0 0
AGE AND SEX DISTRIBUTION
65-74yrs 75+yrs
MALE 17 15
FEMALE 14 14
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MICROORGANISMS ISOLATED IN COMMUNITY
ACQUIRED PNEUMONIA
ORGANISM TOTAL
PERCENTAGE
(N=60)
NO GROWTH 27 45
STAPHYLOCOCCUS AUREUS 5 8.33
STREPTOCOCCUS PNEUMONIAE 4 6.67
KLEBSIELLA PNEUMONIAE 17 28.33
PSEUDOMONAS AERUGINOSA 1 1.67
ACINETOBACTER 1 1.67
PROTEUS MIRABILIS 2 3.33
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PULMONARY TUBERCULOSIS
AGE AND SEX DISTRIBUTION
65-74yrs 75+yrs
MALE 39 20
FEMALE 28 19
CATEGORY WISE PULMONARY TUBERCULOSIS
CATEGORY MALE FEMALE
CATEGORY I
NEW SPUTUM
POSITIVE 30 24
NEW SPUTUM
NEGATIVE 15 9
CATEGORY II
RELAPSE 6 8
FAILURE 5 2
TREATMENT
AFTER DEFAULT 2 3
OTHER - -
DRUG
RESISTANT
TUBERCULOSIS
MONO - -
PDR 1 -
MDR 1 -
XDR - -
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COMORBIDITIES IN PULMONARY TUBERCULOSIS
COMORBIDITY
TOTAL
NUMBER OF
PATIENTS
PERCEN
TAGE
(N=106)
RESPIRATORY
COPD 2 2.12
BRONCHIAL
ASTHMA 1 1.06
SYSTEMIC
DIABETES 39 41.34
CORONARY
HEART DISEASE 4 4.24
SYSTEMIC
HYPERTENSION 11 10.37
OTHERS
ALCOHOLISM 5 5.3
SMOKING 11 11.66
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CLINICAL FEATURES OF PULMONARY TUBERCULOSIS
IN GERIATRIC POPULATION
SYMPTOMS
Percentage
(N=104)
RESPIRATORY
COUGH 76
SPUTUM 74
HEMOPTYSIS 8
CHEST PAIN 6
BREATHLESSNESS 12
CONSTITUTIONAL
FEVER 45
ANOREXIA 94
WEIGHT LOSS 91
NIGHT SWEATS 23
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COPD
AGE AND SEX DISTRIBUTION
64-74yrs 75+yrs
Male 141 62
Female 67 28
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DISEASE SEVERITY IN COPD
STAGE
MALE
(N=203)
FEMALE
(N=95)
I 16.26 15.79
II 21.18 20.00
III 32.02 31.58
IV 30.54 32.63
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ACUTE EXACERBATION OF COPD
65-74yrs 75+yrs
MALE 34 38
FEMALE 25 17
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ASSOCIATION OF RISK FACTORS WITH COPD
RISK FACTOR
MALE
(N=203) %
FEMALE
(N=95) %
ACTIVE SMOKING 98 0
PASSIVE SMOKING 5 38
BIOMASS FUEL 2 84
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CO-MORBIDITIES IN COPD
CO-MORBIDITY
NUMBER
OF
PATIENTS
PERCENTAGE
(N=298)
RESPIRATORY
PNEUMONIA 10 3.36
CA LUNG 30 10.07
PULMONARY
TUBERCULOSIS 2 0.67
SYSTEMIC
CORONARY ARTERY
DISEASE 70 23.49
SYSTEMIC
HYPERTENSION 59 19.80
DIABETES 46 15.44
OTHERS ALCOHOLISM 35 11.74
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MICRO-ORGANISM PROFILE IN AECOPD
MICROORGANISM
NUMBER
OF
PATIENTS
PERCENTAGE
(N=114)
NO GROWTH 56 49.12
STAPHYLOCOCCUS AUREUS 3 2.63
STREPTOCOCCUS
PNEUMONIAE 6 5.26
KLEBSIELLA PNEUMONIAE 32 28.07
PSEUDOMONAS AERUGINOSA 12 10.53
ACINETOBACTER 1 0.88
PROTEUS MIRABILIS 2 1.75
E.COLI 1 0.88
CITROBACTER 1 0.88
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BRONCHIAL ASTHMA
AGE AND SEX DISTRIBUTION
65-74yrs 75+yrs
MALE 47 6
FEMALE 57 7
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SEVERITY OF BRONCHIAL ASTHMA
STAGE
MALE
(N=53)
FEMALE
(N=64)
INTERMITTENT 16.98 17.19
MILD PERSISTENT 32.08 28.13
MODERATE PERSISTENT 35.85 39.06
SEVERE PERSISTENT 15.09 15.63
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ASTHMA EXACERBATION
65-74yrs 75+yrs
MALE 7 1
FEMALE 13 3
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CO-MORBIDITIES IN BRONCHIAL ASTHMA
CO-MORBIDITY
NUMBER
OF
PATIENTS
PERCENTAGE
%
ALLERGIC
DISEASES
ALLERGIC
RHINITIS 35 29.91
URTICARIA 34 29.06
RESPIRATORY
PULMONARY
TUBERCULOSIS 1 0.85
PNEUMONIA 2 1.71
SYSTEMIC
CAD 7 5.98
SYSTEMIC
HYPERTENSION 13 11.11
DIABETES 9 7.69
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PUMONARY TUBERCULOSIS SEQUELAE
65-74yrs 75+yrs
MALE 48 26
FEMALE 33 21
56
COMPLICATION OF PT SEQUELAE
COMPLICATIONS MALE FEMALE
HEMOPTYSIS 3 2
PNEUMONIA 2 1
PULMONARY HYPERTENSION 4 5
CORPULMONALE 3 4
57
CARCINOMA LUNG
HISTOLOGY
MALE
(N=68) %
FEMALE
(N=28) %
SQUAMOUS CELL CARCINOMA 47 32
ADENOCARCINOMA 28 64
LARGE CELL CARCINOMA - -
SMALL CELL CARCINOMA 25 4
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STAGES IN NON SMALL CELL LUNG CANCER
STAGE
MALE
(N=51)
FEMALE
(N=27)
STAGE I 9.80 7.41
STAGE II 11.76 14.81
STAGE III 45.10 44.44
STAGE IV 33.33 33.33
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CO-MORBIDITIES IN CA LUNG
CO-MORDITY NUMBER OF
PATIENTS
PERCENTAGE
(N=96)
RESPIRATORY COPD 30 31.25
SYSTEMIC
DIABETES 16 16.67
SYSTEMIC
HYPERTENSION 8 8.33
CAD 5 5.21
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RISK FACTORS ASSOCIATED WITH  LUNG CANCER
RISK FACTOR
SQUAMOUS
CELL
CARCINOMA
(N=41)
%
ADENO
CARCINOMA
(N=37)
%
SMALL CELL
CARCINOMA
(N=18)
ACTIVE SMOKING 73.17 48.6 77.8
PASSIVE SMOKING 17.07 13.5 5.6
BIOMASS FUEL 19.51 43.2 5.6
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BRONCHIECTASIS
AGE AND SEX DISTRIBUTION
65-74yrs 75+yrs
MALE 15 2
FEMALE 20 3
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COMPLICATIONS OF BRONCHIECTASIS
COMPLICATION
NUMBER OF
PATIENTS
PERCENTAGE
(N=40)
HEMOPTYSIS 3 7.5
PNEUMONIA 5 12.5
PULMONARY
HYPERTENSION 4 10
CORPULMONALE 3 7.5
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MICRO-ORGANISM PROFILE IN BRONCHIECTASIS
ORGANISM
NUMBER OF
PATIENTS
PERCENTAGE
(N=40)
STAPHYLOCOCCUS
AUREUS 2 5
KLEBSIELLA
PNEUMONIA 18 45
PSEUDOMONAS 14 35
ACINETOBACTER 2 5
PROTEUS MIRABILIS 2 5
E.COLI 2 5
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DIFFUSE PULMONARY LUNG DISEASE
DISEASE TOTAL PERCENTAGE
IPF 8 47.06
HYPERSENSITIVITY
PNEUMONITIS 8 47.06
RBILD 1 5.88
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DIFFUSE PULMONARY LUNG DISEASE
SEX DISTRIBUTION
DISEASE MALE FEMALE
IPF 7 1
HYPERSENSITIVITY
PNEUMONITIS
6 2
RBILD 1 0
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COMPLICATIONS OF DPLD
COMPLICATION MALE FEMALE
PHT 2 1
CORPULMONALE 1 1
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PNEUMOCONIOSIS
SILICOSIS
In this study one case of silicosis with progressive massive
fibrosis was found and the case details are as follows
? 68 year old male presented with breathlessness, fever, cough
? No history of prior ATT
? Smoker for past 35 years
? Occupation – digging wells with compressor /drilling
machines/using explosives for rock blasting from age 35 to
52years.
? Sputum AFB negative
? Bronchial wash –AFB negative
? CT chest- hyperdense conglomerate mass of fibrosis  suggestive
of silicosis with progressive massive fibrosis.
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PLEURAL DISEASES
SEX DISTRIBUTION
ETIOLOGY MALE FEMALE
TUBERCULOUS PLEURAL EFFUSION 8 4
MALIGNANT PLEURAL EFFUSION 2 2
PARAPNEUMONIC EFFUSION 6 4
PNEUMOTHORAX 2 2
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PLEURAL DISEASES
DIAGNOSIS AGE DISTRIBUTION
ETIOLOGY 65-74yrs 75+yrs
Tuberculous pleural effusion 11 1
Malignant pleural effusion 1 3
Parapneumonic effusion 6 4
Pneumothorax 4 -
DISCUSSION
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DISCUSSION
In this prospective observational study 1234 patients were studied
in which males were 773 and females were 461.  The age ranged from
65  to  89  years  with  a  mean  age  of  70.1years.  In  the  age  group  of  65-
74years there were 890 patients and 344 in the age group 75+years.
       Respiratory tract infection including upper respiratory tract
infection (28.44%), acute bronchitis(8.75%) , community acquired
pneumonia(4.86%) and pulmonary tuberculosis(8.58%) constitute
50.63% of the morbidity.
Among respiratory infection pulmonary tuberculosis stands
second.Out of the total 106 pulmonary tuberculosis patients  54 were
new sputum positive patients and 24 new sputum negative patients. In
the 26 patients started on category II ATT 14 was due to relapse, 7 due
to failure and 5were started due to treatment after default. Diabetes was
the commonest co morbidity found in Elderly patients with pulmonary
tuberculosis present in 36.79 %. Elderly tuberculous patient presented
more commonly with constitutional symptoms compared to respiratory
symptoms. Tuberculosis with its sequelae constitutes 18.96% of the
morbidity.
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Community acquired pneumonia is third among respiratory tract
infection with diabetes as the commonest comorbidity associated with.
Klebsiella pneumoniae was the commonest organism isolated found in
29% of the patients of community acquired pneumonia.
COPD  is  the  next  major  contributor  with  24%  of  overall
morbidity. It is also the commonest cause for inpatient care as
AECOPD.   Among males 98% of the COPD patients were smokers and
in case of females 38% had exposure to passive smoking and 84% had
exposure to biomass smoke. Most of the COPD patients in this group
were in stage 3 and stage 4 of severity in both males as well as females.
Klebsiella pneumonia and pseudomonas aeruginosa were isolated in
28.07% and 10.53% of the patients with AECOPD.
      There were 117 patients of Bronchial Asthma in this study in
which females contribute 54.7% and males 45.3%. Most of the patients
were in mild persistent (29.9%) and moderate persistent stage (37.6%)
of severity.
 Total number of patients diagnosed to have lung carcinoma
during the period of study was 96 with 58 male patients and 28 females.
Squamous cell carcinoma was the commonest histological pattern
among  all  carcinomas  with  42.71%  and  in  males  it  contributed  to
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47.06%. In females adenocarcinoma was the commonest with 64.29%.
Majority of the elderly patients with lung carcinoma presented in stage
III(44.44%) and stage IV disease(33.33%).  Active smoking was the
major  risk  factor  present  in  92%  of  the  males  and  in  females  it  is
biomass fuel in 67.8% of cases.
       Out of 40 patients with Bronchiectasis 17 were males and 23
were females.
      Idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and
RBILD are three diffuse parenchymal lung disease diagnosed in this
study with 47.06%, 47.06% and 5.88% respectively.
    Pleural  diseases  in  the  elderly  constitute  2.43%  of  the  total.
Infectious causes including tuberculosis and parapneumonic infections
are the commonest etiology with 22 patients followed by 4 cases of
malignancy and 4 cases of pneumothorax.
CONCLUSION
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CONCLUSION
Respiratory Infections and their complications, consisting of
UPPER RESPIRATORY TRACT INFECTION, ACUTE
BRONCHITIS, COMMUNITY ACQUIRED PNEUMONIA,
PULMONARY TUBERCULOSIS AND  ITS SEQUELAE, constitute
the major respiratory morbidity among Geriatric population attending
this tertiary care center.
UPPER RESPIRATORY TRACT INFECTION AND ACUTE
BRONCHITIS is the commonest cause for seeking outpatient care.
 Pulmonary tuberculosis is the second commonest respiratory
infection and ranks fifth in overall respiratory morbidity. Sequelae of
pulmonary tuberculosis causes significant respiratory morbidity in the
elderly constituting about 10.3%.   Pulmonary tuberculosis and its
sequelae together constitute 18.96%.
Among infective disease community acquired pneumonia ranks
third. Diabetes is the commonest co morbidity associated with
community acquired pneumonia.
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COPD is the second most common respiratory morbidity without
any gender difference.Active smoking is the commonest predisposing
factor for COPD in males whereas it is exposure to indoor pollution in
females.AECOPD is the most common cause of inpatient care.
Bronchial asthma constitutes 9.48% of the morbidity.
Carcinoma lung constitutes 7.77%.  Squamous cell carcinoma is
the commonest type of lung cancer among males and it is
adenocarcinoma in females.Active smoking is the commonest risk factor
for lung cancer in males whereas it is exposure to indoor pollution in
females. Lung cancer patients in this age group presented in an
advanced stage.
Idiopathic pulmonary fibrosis is the commonest diffuse
pulmonary lung disease in this age group followed by hypersensitivity
pneumonitis.
Silicosis was the only pneumoconiosis found in this study.
Among pleural diseases infective causes like tuberculous effusion
and parapneumonic effusion was the commonest followed by malignant
pleural effusion and pneumothorax.
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ANNEXURE
Bµõ´a] uPÁÀ uõÒ
ö\ßøÚ Aµ_ ö£õx ©¸zxÁ©øÚUS Á¸® ¬v÷¯õºPÎß (Á¯x 65US 
÷©À) ~øµ±µÀPÎÀ HØ£k® ÷{õ´PÎß uØ÷£õøu¯ |ø» £ØÔ¯ Bµõ´a] 
C[S {øhö£ØÖ Á¸QßÓx. 
¬v÷¯õºPÎß (Á¯x 65US  ÷©À) ~øµ±µÀPÎÀ HØ£k® ÷{õ´PÎß 
uØ÷£õøu¯ |ø»ø¯U PshÔÁ÷u CÆÁõµõ´a]°ß ÷{õUP©õS®.
}[PÐ® C¢u Bµõ´a]°À £[÷PØP {õ[PÒ Â¸®¦Q÷Óõ®. C¢u 
Bµõ´a]°À £[÷PØ£uõÀ u[PÍx ÷{õ°ß B´ÁÔUøP÷¯õ AÀ»x ]Qaø\÷¯õ 
£õv¨¦US EÒÍõPõx Gß£øu²® öu¶ÂzxU öPõÒQ÷Óß. 
¬iÄPøÍ AÀ»x P¸zxPøÍ öÁÎ°k® ÷£õ÷uõ AÀ»x Bµõ´a]°ß 
÷£õ÷uõ u[PÍx ö£¯øµ÷¯õ AÀ»x Aøh¯õÍ[PøÍ÷¯õ öÁÎ°h ©õm÷hõ® 
Gß£øu²® öu¶ÂzxU öPõÒQ÷Óõ®.
C¢u Bµõ´a]°À £[÷PØ£x u[PÐøh¯ Â¸¨£zvß ÷£¶À uõß 
C¸UQÓx. ÷©¾® }[PÒ G¢÷{µ¬® C¢u Bµõ´a]°¼¸¢x ¤ß Áõ[P»õ® 
Gß£øu²® öu¶ÂzxU öPõÒQ÷Óõ®.
C¢u ]Ó¨¦¨ £¶÷\õuøÚPÎß ¬iÄPøÍ Bµõ´a]°ß÷£õx AÀ»x 
Bµõ´a]°ß ¬iÂß÷£õx u[PÐUS AÔÂUP¨£k® Gß£øu²® öu¶ÂzxU 
öPõÒQ÷Óõ®.
Bµõ´a]¯õÍº øPö¯õ¨£® £[÷PØ£õÍº øPö¯õ¨£®
÷uv 
Bµõ´a] J¨¦uÀ Piu®
Bµõ´a] uø»¨¦
¬v÷¯õºPÎß (Á¯x 65US ÷©À) ~øµ±µÀPÎÀ HØ£k® ÷{õ´PÎß uØ÷£õøu¯ 
|ø» £ØÔ¯ B´Ä
ö£¯º : ÷uv             : 
Á¯x : EÒ÷{õ¯õÎ Gs           : 
£õÀ  : Bµõ´a] ÷\ºUøP Gs : 
C¢u Bµõ´a]°ß ÂÁµ[PÐ® Auß ÷{õUP¬® ¬Êø©¯õPÄ® 
öuÎÁõPÄ® GÚUS ÂÍUP¨£mhx. 
GÚUS GUì÷µ, ¤.G¨.i. \Î, Cµzu¨ £¶÷\õuøÚ ©ØÖ® ~øµ±µÀ 
EÒ÷{õUS® P¸Â £¶÷\õuøÚPÒ ö\´x öPõÒÍ \®©u®.
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øPö¯õ¨£®
CURRENT CLINICAL PROFILE OF RESPIRATORY
DISEASES IN GERIATRIC POPULATION
PROFORMA
NAME:
AGE:
SEX:
ADDRESS:
RESPIRATORY COMPLAINTS:
? COUGH:
? SPUTUM:
? HEMOPTYSIS:
? BREATHLESSNESS:
? WHEEZE:
? CHEST PAIN
? HISTORY OF CONTACT WITH TUBERCULOSIS
? FEVER
? LOSS OF WEIGHT
? LOSS OF APPETITE
? NIGHT SWEATS
? OTHERS:
PAST HISTORY :
? HISTORY OF BA, COPD, IHD, SHT, DIABETES MELLITUS
? HISTORY OF PRIOR ATT
? OTHERS
PERSONAL HISTORY
? SMOKING
? ALCOHOL
? SLEEP
? OTHERS
OCCUPATIONAL HISTORY:
FAMILY HISTORY:
GENERAL EXAMINATION
? CONSCIOUS
? COMFORTABLE / DYSPNOEIC
? ANAEMIA
? CYANOSIS
? ICTERUS
? LYMPHADENOPATHY
? CLUBBING
? PEDAL EDEMA
? HEIGHT
? WEIGHT
? BODY MASS INDEX
VITALS
? PULSE RATE
? BLOOD PRESSURE
? RESPIRATORY RATE
SYSTEMIC EXAMINATION
INVESTIGATIONS:
CHEST SKIAGRAM
COMPLETE BLOOD COUNT
RENAL FUNCTION TEST
LIVER FUNCTION TEST
MANTOUX
SPUTUM GRAM STAIN
SPUTUM NT CULTURE AND SENSITIVITY
SPUTUM AFB
ELECTROCARDIOGRAM
ECHOCARDIOGRAM
CT CHEST
BRONCHIAL WASH
BRONCHIAL BIOPSY
PLEURAL BIOPSY

ABSTRACT
Title:  Current clinical Profile of Respiratory diseases in Geriatric
population
Aim             : To study the current trends of Respiratory diseases in
Geriatric population attending  a tertiary care centre.
Method        : Those Geriatric patients who have respiratory
symptoms will be taken up for study. All patients
will be subjected to physical examination, chest
skiagram, mantoux, basic blood investigations,
sputum AFB, NT C/S, G.Stain, pulmonary function
test, CT chest and  bronchoscopy if indicated
Inclusion
Criteria        : Consenting patients of age >65 years with respiratory
complaints
Exclusion
Criteria        : Patients less than 65 years of age. Patient not giving
consent.
Results         :     Respiratory Infections and their complications,
consisting of UPPER RESPIRATORY TRACT
INFECTION, ACUTE BRONCHITIS,
COMMUNITY ACQUIRED PNEUMONIA,
PULMONARY TUBERCULOSIS AND
ITSSEQUELAE constitute the major respiratory
morbidity among Geriatric population attending this
tertiary care centre.Pulmonary tuberculosis is the
second commonest respiratory infection and ranks
fifth in overall respiratory morbidity. Sequelae of
pulmonary tuberculosis cause significant respiratory
morbidity in the elderly constituting about 10.3%.
Pulmonary tuberculosis and its sequelae together
constitute 18.96%.
COPD is the second most common respiratory
morbidity without any gender difference. Active
smoking is the commonest predisposing factor for
COPD in males whereas it is exposure to indoor
pollution in females. AECOPD is the most common
cause of inpatient care.
Bronchial asthma constitutes 9.48% of the morbidity.
Carcinoma lung constitutes 7.77%.  Squamous cell
carcinoma is the commonest type of lung cancer
among males and it is adenocarcinoma in females.
Active smoking is the commonest risk factor for lung
cancer in males whereas it is exposure to indoor
pollutionfuel in females. Lung cancer patients in this
age group presented in an advanced stage.
Idiopathic pulmonary fibrosis is the commonest
diffuse pulmonary lung disease in this age group
followed by hypersensitive pneumonitis.
Silicosis was the only pneumoconiosis found in this
study.
Among pleural diseases infective causes like
tuberculosis and parapneumonic was the commonest
followed by malignancy and pneumothorax.
Conclusion Respiratory infections including upper respiratory
tract infection, acute bronchitis, pneumonia,
tuberculosis constitute more than 50% of the
respiratory morbidity. Followed by chronic
obstructive pulmonary disease in both males as well
as females. Pulmonary tuberculosis and its sequelae
together almost cause one fifth of the morbidity
(18.96%).
